Abstract:OBJECTIVES(1) To investigate the levels of the serum soluble endothelial growth factor receptor-1 in women with preeclampsia and compare the difference between the groups of the mild preeclampsia, severe preeclampsia and eclampsia. For more, to analyze the relativity between the levels of the serum soluble vascular growth factor receptor-1 and preeclampsia. (2) To detect the expression of the membrane-bound VEGFR-1 protein in the placenta tissue of the women with preeclampsia and compare the difference between the groups of the mild preeclampsia, severe preeclampsia and eclampsia, Then to analyze the relativity between the expression of the membrane-bound endothelial growth factor receptor-1 and preeclampsia.METHODS(1) The serum levels of sVEGFR-1 in 10 women with mild preeclampsia, 10 women with severe preeclampsia, 10 women with eclampsia, 10 women without preeclampsia were detected by the quantitative sandwich enzyme immunoassay technique. (2) Immunohistochemistry and quantitative analysis were used to detect membrane-bound VEGFR-1 contents and distribution in the placenta tissue.RESULTS(1) The results showed that the serum sVEGFR-1 levels of all preeclampsia groups were relatively higher than those of control group (P < 0.05) and that there were significant differences between the groups of the mild preeclampsia, severe preeclampsia and eclampsia. (2) In placentas, the positive staining was detected predominantly in the membranes of villus syncytiotrophoblast cells, extravillous trophoblast cells, and villus endothelial cells. In fetal membranes, the positive staining was detected predominantly in amnionic endothelial cells. (3) The contents of membrane-bound VEGFR-1 in placenta of preeclampsia groups were relatively lower than that of control group. There were significant differences between membrane-bound VEGFR-1 contents of the mild preeclampsia,severe preeclampsia and eclampsia (P < 0.05). (4) The ratio of the sVEGFR-1 concentration in serum and the membrane-bound VEGFR-1 contents in placenta of preeclampsia groups (sVEGFR-1/ membrane-bound VEGFR-1) was relatively higher than that of control group (P < 0.05) and there were significant differences between the groups of the mild preeclampsia, severe preeclampsia and eclampsia (P < 0.05).CONCLUSIONS(1) The serum sVEGFR-1 levels of preeclampsia groups were relatively higher than those of control group, the VEGFR-1 may be related to preeclampsia. (2) The contents of membrane-bound VEGFR-1 in placenta of preeclampsia groups were relatively lower than that of control group, the membrane-bound VEGFR-1 may relate to preeclampsia. (3) The ratio of the sVEGFR-1 concentration in serum and the membrane-bound VEGFR-1 contents in placenta of preeclampsia groups (sVEGFR-1/membrane-bound VEGFR-1) was relatively higher than that of control group, the preeclampsia may contribute to VEGFR-1/ PLGF and sVEGFR-1/membrane-bound.

[Predictive Value of Soluble Vascular Endothelial Growth Factor Receptor 1 for Preeclampsia in Second-Trimester].

The value of serum angiogenic factors for predicating development of preeclampsia

Progress in Soluble Vascular Endothelial Growth Factor Receptor-1 and Preeclampsia

Value of a ratio of sFlt-1 to PLGF in prospecting the preeclampsia

Expression and significance of soluble fms-like tyrosine kinase-1 in preeclampsia

The Expression of Serum Segfr, Sflt-1, Sendoglin and PLGF in Preeclampsia

Clinical Usefulness of Soluble Fms-Like Tyrosine Kinase 1, Soluble Endoglin and Placental Growth Factor in Korean Women with Preeclampsia

Soluble fms-like tyrosine kinase 1 and placental growth factor ratio for predicting preeclampsia in elderly gravida

Clinical Validation of the sFlt-1:PlGF Ratio as a Biomarker for Preeclampsia Diagnosis in a High-Risk Obstetrics Unit

[The Relativity of Vascular Endothelium Growth Factor Receptor-1 and Preeclampsia].

Changes of Serum Pregnancy-Associated Plasma Protein-A,Placental Growth Factor and Solu-ble Fms-Like Tyrosine Kinase Receptor-1 Concentrations in Preeclampsia Patients

The Predictive Value of Maternal Plasma Fibronectin Level for Hypertensive Disorder Complicating Pregnancy at Different Stages of Gestation

Short-Term Prediction of Preeclampsia in Chinese Women Using the Soluble Fms-Like Tyrosine Kinase 1/placental Growth Factor Ratio: A Sub-Analysis of the PROGNOSIS Asia Study

Expression and clinical implication of endothelial glycoprotein,vascular endothelial growth factor and its receptor 1 in preeclampsia

Combination of Maternal Serum ESM-1 and PLGF with Uterine Artery Doppler PI for Predicting Preeclampsia

Serum Protein Marker Panel for Predicting Preeclampsia.

762: Risk for preeclampsia and intrauterine growth restriction: effective value of PlGF, Sflt-1 and Inhibin A in singleton and multiple pregnancies

Predicting Preeclampsia Pregnancy Termination Time Using sFlt-1

Study the Value of ED1+Fn in Predicting Preeclampsia

sFlt-1/PlGF ratio at 24 weeks gestation in twin pregnancies as a predictor of preeclampsia or fetal growth restriction

Analysis of Predictive Information From Biomarkers Added to Clinical Models of Preeclampsia: Consideration of PAPP-A2, Activin A, and sFlt-1:PlGF Ratio